https://www.selleckchem.com/pr....oducts/4-Methylumbel
01) for metabolic syndrome diagnosis and 0.945 (P0.05) for moderate to high CVD risk classification. Associations between SCS and composite CVD risk indicators were null when adjusted for the corresponding plasma carotenoids, indicating complete mediation. Dietary carotenoids, however, showed no relationship with the CVD risk indicators. Carotenoids bioavailability may be important for cardiovascular protection. SCS, driven by the corresponding plasma carotenoids, could be a potential noninvasive surrogate marker
Curtir
Comentario
Compartilhar
